Tilray® to Acquire Natura Naturals Holdings Inc. for up to C$70 Million Subject to Performance Milestones

Tilray, Inc. (“Tilray” or “the Company”) (NASDAQ:TLRY), a global leader in cannabis research, cultivation, production and distribution, today announced it has entered into a definitive agreement (“the Agreement”) pursuant to which Tilray, through a wholly-owned subsidiary, will acquire all of the issued and outstanding securities of Natura Naturals Holdings Inc. (“Natura”), the parent company of a licensed cultivator of cannabis.

Privateer Holdings Inc. Provides Guidance On Unwinding It's Position In Tilray

Privateer Holdings Inc. (Privateer), the world’s first and leading private equity firm investing exclusively in the emerging legal cannabis industry, today issued the following statement, strongly emphasizing that it does not have plans to register, sell or distribute the 75 million shares that Privateer owns in Tilray, Inc. (NASDAQ:TLRY) when the lock-up expires next week.

Tilray® Signs Letter of Intent for Hemp-Derived CBD from the U.S. and Canada

Tilray, Inc. (NASDAQ:TLRY), a global leader in cannabis research and production, today announced the terms of a binding letter of intent to purchase hemp-derived CBD isolate from LiveWell Canada Inc. (CSE:LVWL), which will be sourced from the United States and Canada and utilized for distribution of Tilray-owned wellness and medical products across North America.

Tilray® Announces New Subsidiary Tilray Latin America

Tilray, Inc. (NASDAQ: TLRY) (“Tilray”), a global leader in cannabis research and production, today announced that after completing an acquisition of its existing import and distribution partner Alef Biotechnology SpA (“Alef”), the company has officially relaunched as Tilray Latin America SpA (“Tilray Latin America”), a wholly-owned subsidiary of Tilray.

3 Canadian Cannabis Leaders To Watch This Week

The legalization of recreational cannabis in Canada has proven to be a “sell the news” type of event and we are monitoring how the cannabis sector trades from here.

This pullback has taken place while the overall stock market has been under pressure and this is an important trend to monitor. Today, we have highlighted three Canadian cannabis producers that are worth watching.

Canopy: A Global Cannabis Leader

Tilray® Receives Approval from U.S. Government to Import a Medical Cannabis Study Drug for a Clinical Trial at the University of California San Diego Center for Medicinal Cannabis Research

Tilray Inc. (NASDAQ:TLRY) today announced that the U.S. Drug Enforcement Administration (DEA) has granted approval to import a cannabinoid study drug into the United States from Canada for a clinical trial at the University of California San Diego (UC San Diego) Center for Medicinal Cannabis Research (CMCR) examining its safety, tolerability and efficacy for Essential Tremor (ET).

Pages